Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma | Business Wire Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Source: Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma […]
Market conditions continue to show subtle signs of improvement! New this week…
Gemini Staffing Announces New Hire
Year In Review – Recent Staffing Highlights
Attention Clinical Operations Directors: We have a unique opportunity with a Metro Boston-based biotech that is developing novel precision oncology programs. If you would like to learn about a company that offers what many can’t – a robust pipeline, an unrivaled veteran leadership team, a strong financial standing and a workplace that attracts and retains its people – we would love to hear from you. Please contact us today!
Featured Role – Director/Senior Director, Regulatory CMC – Remote, East Coast preferable